Report Code: A03885 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Peripheral Intervention Drug-eluting Devices Market
Request Now !Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Factors such as rise in geriatric population, high incidence of peripheral artery disease (PAD), advancement of technology in peripheral intervention devices, increased demand for minimal invasive procedures, and demand for drug coated devices to show antirestenotic effect drive the market growth. However, availability of conventional treatments and product recalls restrain the market growth. Moreover, introduction of bioresorbable stents and development of healthcare infrastructure regarding peripheral diseases in untapped market provide opportunities for the market growth.
The peripheral intervention drug-eluting devices market is segmented on the basis of procedure, type, and region. On the basis of procedure, it is divided into plain old balloon angioplasty (POBA) and percutaneous transluminal angioplasty (PTA). On the basis on type, it is classified into drug-eluting balloons and drug-eluting stents. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players in the market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., St. Jude Medical, Inc., The Lubrizol Corporation, and Terumo Corporation.
Key Benefits
Peripheral Intervention Drug-Eluting Devices Market Report Highlights
Aspects | Details |
---|---|
By Procedure |
|
By Type |
|
By Region |
|
Key Market Players | Cardinal Health, C.R. Bard, Inc., Medtronic plc, B. Braun Melsungen AG, The Lubrizol Corporation, Biosensors International Group Ltd., Terumo Corporation, Abbott Laboratories, St. Jude Medical, Inc., Boston Scientific Corporation |
Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers